Balasa Dinverno & Foltz’s Amgen AMGN Stock Holding History

Balasa Dinverno & Foltz’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.31M	Sell	5,812 -458	-7%	-$111K	0.08%	97
2022 Q2	$1.52M	Buy	6,270 +242	+4%	+$59.3K	0.1%	86
2022 Q1	$1.46M	Sell	6,028 -135	-2%	-$31K	0.1%	94
2021 Q4	$1.39M	Sell	6,163 -1,212	-16%	-$256K	0.09%	100
2021 Q3	$1.57M	Sell	7,375 -632	-8%	-$145K	0.11%	90
2021 Q2	$1.95M	Buy	8,007 +273	+4%	+$67.2K	0.14%	70
2021 Q1	$1.92M	Buy	7,734 +34	+0.4%	+$8.11K	0.15%	68
2020 Q4	$1.77M	Sell	7,700 -123	-2%	-$28.4K	0.15%	63
2020 Q3	$1.99M	Buy	7,823 +458	+6%	+$113K	0.19%	49
2020 Q2	$1.74M	Buy	+7,365	New	+$1.68M	0.19%	50

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balasa Dinverno & Foltz's AMGN Position: Q3 2022 in Review

Balasa Dinverno & Foltz reduced its Amgen (AMGN) stake by 7.3% in Q3 2022, selling an estimated $111K and leaving 5,812 shares worth $1.31M. The position accounts for 0.08% of the portfolio, ranked #97.

Balasa Dinverno & Foltz first reported a position in AMGN in Q2 2020 and has held it in 10 quarters since. The position peaked at $1.99M in Q3 2020. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Balasa Dinverno & Foltz held 5,812 shares of Amgen worth $1.31M as of Q3 2022.
Balasa Dinverno & Foltz sold 458 Amgen shares in Q3 2022, an estimated $111K.
Amgen made up 0.08% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #97 holding.
Balasa Dinverno & Foltz first reported a position in Amgen in Q2 2020 and has held it in 10 quarters since.
Balasa Dinverno & Foltz's Amgen position peaked at $1.99M in Q3 2020.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.